Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis
By LabMedica International staff writers Posted on 15 Feb 2024 |

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique. Over the past decade, PA imaging has gained traction as a practical imaging modality in various clinical settings where it has demonstrated encouraging results. While traditional diagnostic methods are invasive, PA imaging offers a noninvasive alternative for examining biological tissues. However, its broad clinical application has been hampered by the bulkiness and high cost of laser sources. Now, researchers have introduced a groundbreaking, compact, and affordable PA sensing instrument for biomedical tissue diagnosis. Their proof-of-concept study, utilizing cost-effective diode lasers, marks a significant step toward the transition of PA imaging from laboratory research to clinical application.
For the study, researchers from the IIT Indore (Madhya Pradesh, India) focused on the complex nature of breast tissue, specifically fibrocystic changes, which often present diagnostic challenges due to similarities with breast cancer. These changes can cause breast pain and detectable cysts and are frequently found in peritumoral breast parenchyma, complicating diagnoses. Traditional diagnostic methods like ultrasound and mammography sometimes lack the necessary precision, and fine needle aspiration cytology, a common diagnostic tool, often requires additional invasive procedures for confirmation. The PA technique, leveraging laser diodes, generates acoustic waves that provide critical insights into tissue composition and density.
The novel instrument incorporates multiple laser diodes in a compact design, coupled with a custom-built pulsed current supply unit, producing efficient PA excitation with 25 nanosecond pulses at 20 kHz. The researchers were able to distinguish between normal and diseased breast tissues by analyzing the frequency spectra of PA signals. Analyzing the frequency spectra allowed for quantitative tissue assessment. For example, fibrocystic breast disease showed a dominant frequency peak at around 1.60 MHz, suggesting increased tissue density, while normal breast tissue had a lower peak frequency of 0.26 MHz, indicative of its fibrofatty composition.
Histopathological examinations confirmed these observations, aligning spectral responses with tissue characteristics. The experimental setup differentiated tissue types based on quantitative spectral parameters, enhancing diagnostic accuracy and potentially simplifying the sampling process for pathological breast tissues. The compact PA sensing instrument could emerge as a promising tool for clinical practice, offering rapid, reliable, and cost-effective breast disease diagnosis. This breakthrough paves the way for timely interventions and improved patient outcomes, revolutionizing biomedical practices with a cost-effective and rapid tissue diagnosis approach.
Related Links:
IIT Indore
Latest Pathology News
- New Test Diagnoses High-Risk Childhood Brain Tumors
- Informatics Solution Elevates Laboratory Efficiency and Patient Care
- Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
- New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
- New Technique Predicts Aggressive Tumors Before They Metastasize
- Butterfly Wings-Inspired Imaging Technique Enables Faster Cancer Diagnosis
- Machine Learning Tool Enables AI-Assisted Diagnosis of Immunological Diseases
- AI-Driven Tool to Accelerate Cancer Diagnosis
- Revolutionary AI Tool Transforms Disease Visualization
- Novel Dataset of Plasma Cells to Aid Diagnosis of Multiple Myeloma
- New Metabolite Detection Method Using DNA Sequencing Could Transform Diagnostics
- AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC
- Cutting-Edge Medical Device Purifies and Concentrates Urine for Rapid Cancer Diagnosis
- Blood Test Measures Lipoprotein (a) in Molar Units for Better Cardiovascular Risk Assessment
- Long-Read Sequencing to Improve Diagnosis Rate of Rare Diseases
- AI Enhances Cervical Cancer Detection
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Portable Blood-Based Device Detects Colon Cancer
Colon cancer is the second leading cause of cancer-related deaths in the U.S., yet it is highly treatable when detected at an early stage. Traditional colonoscopy screenings, although effective, are unpleasant,... Read more
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more